Gujarat doc leads 1st clinical trial to potentially prevent millions of annual heart failures/deaths

RAJKOT, India - Oct. 3, 2026 - PRLog -- For decades, the golden rule of treating a severe heart attack has been clear: open the blocked artery as fast as possible. This life-saving procedure is the undisputed champion of heart attack care. But a groundbreaking international study, SHIELD-MI, reveals we can do even more to help the heart heal after the artery is reopened. Presented at the ESC Congress 2026 and published in the European Heart Journal, this research marks a massive leap forward in patient recovery.

The Challenge of a Fragile Heart

Emergency procedures to open a blocked artery (like angioplasty and stenting) are medical miracles that stop a heart attack by rapidly restoring blood flow. However, a severe heart attack (STEMI) still leaves a mark. Because the muscle was starved of oxygen, the tissue becomes extremely fragile. In many patients, this leads to intramyocardial hemorrhage—deep bruising and bleeding inside the weakened heart muscle.

This deep bruising is the most severe stage of heart injury. It complicates recovery and increases the risk of future heart failure. Until now, doctors had no specific way to treat this underlying bruising; they could only open the artery and wait for healing.

The SHIELD-MI Breakthrough

The SHIELD-MI trial asked a game-changing question: What if we could actively treat this deep heart bruising alongside standard care?

Working across the United States and India, researchers found the answer. The study provides the very first clinical evidence that doctors can actively treat and reduce this deep bruising after a heart attack.

The trial's name perfectly captures its goal. While standard procedures restore vital blood flow, this complementary therapy acts as a "shield," protecting the recovering heart muscle so it heals as strongly as possible.

"Time is Muscle, Muscle is Outcome"

"Primary PCI [opening the artery] saves myocardium by restoring blood flow, but our work asks what we can do for the myocardium that remains vulnerable after reperfusion," explained Dr. Keyur P. Vora, the Lead Clinical Trial Investigator and First Author of the study.

Dr. Vora emphasized that by proving this deep bruising can be treated, medicine now has a powerful new target for heart attack care. "If Time is Muscle, Muscle is Outcome," he noted, pointing out that protecting more recovering heart muscle directly leads to better survival rates and healthier lives.

What This Means for the Future

By proving we can shield the heart from post-attack bruising, SHIELD-MI opens an entirely new direction in cardiovascular research. This clears the path for advanced strategies that will drastically reduce heart failure, ensuring heart attack survivors worldwide can return to fuller, healthier lives.

https://www.youtube.com/watch?v=l5V_tltnXQI (https://clinicaltrialresults.org/dr-keyur-vora-and-dr-c-m...)